Medical cannabis has been legal since November 1st 2018 and yet patients are still having difficulty accessing products. We sat down with two companies, one big one small, who want to fill that gap.
Following on from becoming the first Asian country to legalise medical cannabis in November. South Korean Authorities announced last Tuesday that the country would be accepting its first shipment of medical cannabis next month.
Cannabidiol or CBD has been getting a lot of press lately. This substance from the cannabis plant is generally regarded as non-intoxicating, with the feeling of being high associated with consumption of tetrahydrocannabinol aka THC.
[cmsmasters_row][cmsmasters_column data_width=”1/1″][cmsmasters_text] The two day conference in Chelsea, London shone with the vitality of cannabis related business, not only were there great diversity in businesses represented, the… Read more “Future Cannabis Strategies Europe 2019”
Professor Nutt’s scheduled debate became a lecture when the Royal College of Psychiatrists could find no one to oppose him! Click to view
Today’s article in the Spectator may have read very differently if the Author had heard the President’s Lecture at the Royal College of Psychiatrists (RCP) On Wednesday,… Read more “Is Cannabis ‘driving us mad?’ Or is madness driving us to Cannabis?”
Source: Canopy Growth Spectrum Biomedical UK (Spectrum UK) is a newly formed company focused on providing access of cannabis-based medicinal products to UK patients with severe clinical… Read more “Canopy Growth enters the UK”